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Abstract
The generation of hematopoietic stem cells (HSCs) during development is a complex process linked to morphogenic
signals. Understanding this process is important for regenerative medicine applications that require in vitro production
of HSC. In this study we investigated the effects of canonical Wnt/β-catenin signaling during early embryonic
differentiation and hematopoietic specification using an embryonic stem cell system. Our data clearly demonstrates
that following early differentiation induction, canonical Wnt signaling induces a strong mesodermal program whilst
maintaining a degree of stemness potential. This involved a complex interplay between β-catenin/TCF/LEF/
Brachyury/Nanog. β-catenin mediated up-regulation of TCF/LEF resulted in enhanced brachyury levels, which in-turn
lead to Nanog up-regulation. During differentiation, active canonical Wnt signaling also up-regulated key transcription
factors and cell specific markers essential for hematopoietic specification, in particular genes involved in establishing
primitive erythropoiesis. This led to a significant increase in primitive erythroid colony formation. β-catenin signaling
also augmented early hematopoietic and multipotent progenitor (MPP) formation. Following culture in a MPP specific
cytokine cocktail, activation of β-catenin suppressed differentiation of the early hematopoietic progenitor population,
with cells displaying a higher replating capacity and a propensity to form megakaryocytic erythroid progenitors. This
bias towards erythroid lineage commitment was also observed when hematopoietic progenitors were directed to
undergo myeloid colony formation. Overall this study underscores the importance of canonical Wnt/β-catenin
signaling in mesodermal specification, primitive erythropoiesis and early hematopietic progenitor formation during
hematopoietic induction.
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Introduction
Wnt proteins are highly insoluble glycoproteins, which remain
associated with the cell surface or extracellular matrix of the
cell following secretion [1]. Consequently, Wnt proteins tend to
act in an autocrine or spatially confined paracrine fashion,
targeting cells in close proximity. The expression of Wnt target
genes is regulated by nuclear β-catenin that is bound to the
transcription factors of the TCF/LEF family [2]. Canonical Wnt/
β-catenin signaling is essential for orientating the
anteroposterior axis and generating mesoderm which precedes
primitive hematopoiesis [3,4]. Wnts, their receptors and active
β-catenin are highly expressed in embryonic hematopoietic
tissues indicating an essential role for Wnt signaling in
developmental hematopoiesis [1]. Recent studies have clarified
the role of individual Wnts during hematopoietic ontogeny and
more importantly how canonical Wnt signaling affects primitive
and definitive hematopoietic specification. Wnt 16 has been
demonstrated to play a role in the earliest specification of
hematopoietic stem cells (HSCs) [5] which correlate to the high
expression observed in the Aorta, Gonads and Mesonephros
region (AGM) during mouse development [6]. Wnt 5a has also
been identified as a regulator of early hematopoietic stem cells
and is highly expressed in early mouse embryonic tissues (Yolk
Sac (YS) and AGM), and primitive hematopoietic progenitors
[1,7,8]. In Xenopus Wnt 4 has been identified as essential for
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the formation and maintenance of the ventral blood islands [9].
Interestingly Wnt 3a is tightly regulated only being detected in
the AGM and for a defined period E15-16 in the fetal liver (FL)
[7,8]. This corresponds to the stages when the first HSCs are
generated and then migrate and undergo a large expansion in
the FL [10,11]. Wnt 3a deficiency results is embryonic lethality
[12] with analysis of FL at E12.5 of embryonic development
revealing that this is accompanied by reduced numbers of long-
term HSC and multipotent progenitors (MPP), which are
severely and irreversibly impaired in long-term reconstitution
capacity as observed in serial transplantation assays [13].
Canonical Wnt signaling has recently been shown to be
essential for HSC generation in the AGM at E10.5, with
hematopoietic precursors arising from CD31+, c-Kit-
endothelial-like precursors that express VE-cadherin.
Subsequent to this stage β-catenin signaling is dispensable for
HSC establishment but can modulate HSC behavior as
demonstrated by increased reconstitution potential following
activation of the pathway [14]. These studies support a key role
for canonical Wnt pathway in the early stage of establishing
hematopoiesis in vertebrates.
In adult hematopoiesis, loss- and gain- of function of β-
catenin combined with cre-mediated recombination to target
the HSC population has produced conflicting views regarding
the importance of β-catenin for normal HSC function.
Conditional deletion of β-catenin using Vav-1-Cre impaired
HSC self-renewal [15,16], supporting studies using the Wnt-
negative regulator Dickkopt 1 [17] and Wnt3a deficient mice
[13]. Whereas Mx-Cre-mediated deletion of β-catenin [18] or β-
and γ-catenin simultaneously had no effect on hematopoiesis
[19,20]. Similarly gain of function approaches have been
controversial with stabilized forms of β-catenin either resulting
in exhaustion of the HSC pool and failure to reconstitute the
hematopoietic system in transplantation assays [21,22] or
enhancement of HSC function and maintenance of an
immature phenotype [15,23-25].These findings may be
explained in part by the differing levels of canonical Wnt
signaling achieved using these systems. Indeed combinations
of hypomorphic allele mutations and a conditional deletion
allele of the adenomatous polyposis coli (APC) gene to
modulate in vivo canonical Wnt signalling, revealed that mild to
moderate activation of the pathway is advantageous resulting
in increased clonogenic and differentiation potential with
greater reconstitution potential of HSCs, whereas high levels of
activation resulted in a differentiation block and failure to
reconstitute irradiated recipient mice [26].
Although these studies provide important information on the
role of canonical Wnt/β-catenin signaling in steady state
homeostasis the ability to study early embryonic hematopoiesis
has been hindered by the inability to specifically over-express/
delete key components of this pathway during embryogenesis.
Mouse embryonic stem (ES) cells therefore provide an ideal in
vitro model for studying both the initiation of primitive
hematopoiesis and later stages when more definitive
hematopoiesis becomes established [8,27-29]. Following the
induction of differentiation, ES cells generate colonies known
as embryoid bodies (EB) containing developing cell populations
of all three germ layers [29-31]. Mesoderm-derived populations
within these developing EB can be directed to form
hemangioblasts [32–34] with the capacity to undergo further
hematopoietic lineage commitment to form myeloid, erythroid
and lymphoid cells. This system has been well characterized
through gene expression and progenitor cell analysis and
shown to closely parallel hematopoietic commitment during
embryogenesis [8,33,34]. Using ES differentiation models, it
has previously been demonstrated that Wnt, BMP and Activin
signaling are important for establishing primitive hematopoietic
commitment via the Cdx-Hox axis with Wnt signaling being
involved in primitive erythroid colony formation [9,35-37].
To characterise the role of the canonical Wnt/β-catenin
signal transduction pathway in early cell specification and more
specifically early hematopoietic differentiation, we have utilised
ES cells as an in vitro model. Activation of the pathway at
different stages of differentiation was achieved using
complementary pharmacological and genetic approaches. We
demonstrate that β-catenin dependent signaling induces a
strong mesodermal program whilst maintaining a degree of
stemness potential during early differentiation induction. This is
accompanied by a strong induction of genes involved in
primitive hematopoietic development. When directed to
undergo hematopoietic differentiation, β-catenin signaling
enhanced this process by promoting early hematopoietic and
MPP, megakaryocytic erythroid progenitors (MEP) and
erythroid colony formation. Overall, we demonstrate that the
canonical Wnt pathway enhances developmental
hematopoiesis processes, especially primitive and more
definitive erythropoiesis.
Materials and Methods
Cell culture and generation of transfectants
Dominant positive ΔGSKβ-catenin (DP-βC), with the CK1
and GSK-3 binding sites Serine 33, 37, 45 and threonine 41
mutated to alanine by site-directed mutagenesis, (Kindly
provided by Dr. Barth, Stanford, USA) was cloned into
pUHD10-3 neomycin and transfected into E14tga murine ES
cells expressing the tetracycline-sensitive transactivator, tTA.
The β-catenin mutation resulted in a dominant positive form,
(DP-βC), resistant to proteosomal degradation. Culture,
selection and screening of clones were performed as
previously described [38]. For the induction of DP-βC, cells
were washed x3 in PBS and incubated in the absence of
tetracycline for 24 h or as indicated.
Proliferation & self-renewal assays
XTT bioreduction assays and trypan blue exclusion were
performed as previously described [38] to assess the IC50 of
the pharmacological inhibitors 6-bromoindirubin-3’oxime/BIO,
and XAV939 (Calbiochem). Self-renewal of parental ES cells
plus the pharmacological inhibitor 5 μM BIO, 5 μM & 10 μM
XAV, or dimethyl sulfoxide alone and DP-βC ES cells plus and
minus tetracycline were analyzed using alkaline phosphatase
staining. Cells were washed, fixed in methanol and then
stained for 15 minutes with 1 mg/mL Fast Red TR salt TM
(Sigma) dissolved in 0.1 M Tris pH 9.2 containing 200 µg/mL
Napthol AS-MX phosphate.
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RT-PCR and TaqMan Mouse Stem Cell Pluripotency
Array cards
Total RNA was prepared using RNAeasy Plus extraction kit
(Qiagen). RNA (1 μg) was reverse-transcribed using
Superscript reverse transcriptase and oligo dT primers
(Invitrogen Life Technologies). Semi-quantitative PCR was
performed using 2 μL cDNA and standard conditions using
gene-specific primers with non-saturating cycle-numbers
(24-32 cycles). Quantitative PCR was performed using 2 μL
cDNA with gene specific primers (Table S1) and 2x TaqMan
Universal PCR Master Mix (Applied Biosystems) on an Applied
Biosystems Prism 7900HT system. The 2-ΔΔCT method was
used to calculate relative expression levels for each gene. RNA
was reverse-transcribed using a High Capacity cDNA Reverse
Transcription kit (Applied Biosystems) and PCR performed
using the Applied Biosystems® TaqMan® Mouse Stem Cell
Pluripotency Array (4385363) as per manufacturer instructions.
Data was quantified using RQ Manager Analysis software.
Relative gene expression was calculated using the 2-ΔΔCT
method. Genes included for analysis had a CT value ranging
between 18-35, with the ΔCT calculated using the average CT
from five endogenous controls as reference genes. Following
calibration using the control samples (-DP-βC or -BIO) the RQ
ratio (arbitory units) of the test sample (+DP-βC or +BIO) were
plotted as fold increase/decrease as a measure of mRNA gene
expression. Transcriptional changes of >2.0 fold change were
included in the analysis.
Immunoblotting and antibodies
Immunoblotting was performed for; Phospho-STAT 3 (9131),
Phospho-Akt substrate (9614), GAPDH (2118), TCF1, TCF4 &
LEF1 (9383) (Cell Signaling Technologies), STAT 3 (sc-7179),
Nanog (sc-134218, Santa Cruz), Total GSK 3 (05-412), Active
β-catenin (05-665, Upstate-Millipore), Total β-catenin (610154),
anti-GSK3β Tyr 216 (612313, BD Transductions) and
Brachyury (20680, Abcam) as previously described [38].
Flow cytometry
For immunostaining analysis, cells were harvested,
resuspended at 0.5 x 107 cells per mL of FACS Buffer (PBS
with 2% FCS and 0.02% sodium azide) and incubation with 1
µg of Rat Anti-Mouse CD16/CD32 Fc Block™ (Becton
Dickinson, BD 553142) for 30 min, 4°C. For intracellular
staining, the cells were harvested, blocked, washed x 2 with
FACS Buffer prior to fixing and permeabilization using FIX &
PERM® Kit (BD) as per manufacturer’s instructions. Labelling
was performed using 0.5 μg of each flurochrome conjugated
antibody or relevant isotype control for 1 h, 4°C in the dark.
Secondary staining was performed for a further 30 min for any
indirect stains. Brachyury (Abcam 20680), Nanog (560277),
Oct3/4 (9006287), Sox2 (9006407), CD11b (552850), Flk1
(555308), CD24 (55313137), CD41 (556437), CD44 (560451),
CD45 (557235), c-Kit (553356), Sca1 (558162), Gr1 (553129)
and Flt3 (553842) all from BD, CD71 (113802), Ter119
(116205, Bio-legend), FITC Secondary (BD 554020), Step-
Avidin Secondary (BD 554064) were used. Following washing,
cells were analyzed on a FACSCanto™ II flow cytometer (BD)
and data analysed using FlowJo software (Treestar). For
isolation of hematopoietic populations cells were
immunostained and isolated on a FACSAria™ cell sorter flow
cytometer (BD).
Chromatin Immunoprecipitation (ChIP)
ChIP was performed using a previously described method
[39]. In brief parental cells +/- BIO or DP-βC cells +/- Tet were
cultered for 4 days minus LIF. 20 x 106 cells were
formaldehyde treated to cross-link DNA-protein interactions
and reaction stopped using Glycine. Cells were lysed in cell
lysis buffer and nuclei were pelleted, resuspended in nuclei
lysis buffer (NLB) and incubated for 10 min, 4°C. IP dilution
buffer (IPDB) was added and nuclei sonication on ice to obtain
300-1000 bp fragments of sheared DNA. Fragments were
collected by centrifugation, resuspended in NLB:IPDB and
chromatin precleared using 100 µl Rabbit serum, 1 h at 4°C.
Protein G-agarose (100 μl of the bed volume) was added and
incubated overnight at 4°C. Antibody-agarose complexes were
pelleted and the chromatin supernatant divided into five
portions, one was stored as input (positive control) and the
other four immunoprecipitated with 2 µg; Stat 3, Brachyury,
TCF/LEF-1 or IgG (as a negative control) antibody at 4°C
overnight. Protein G-agarose (50 μl of the bed volume) was
added and incubated for 3 h at 4°C. The Protien G-agarose-
complexes were collected by centrifugation, washed x 2 in low
salt IP wash Buffer x 2 in high salt IP wash buffer and x 2 with
TE buffer, pH 8.0. To reverse the cross links, IP Elution buffer
was added. The samples were incubated with RNase A at
65°C for 6 h and proteinase K treated overnight at 45°C. DNA
was extracted using phenol chloroform and analysis performed
using PCR with ChIP specific primers (Table S2 (i) & (ii)).
Hematopoietic differentiation
Primary EB (Day 4) and early hematopoietic progenitor
formation (Day 8) were carried out as previously described [8].
For primitive erythroid colony formation EB’s were harvested
[40,41] and a single cell suspension plated at 2.5 x 104/mL in
methylcellulose medium containing IL-3, IL-6, EPO and SCF
(M3434; StemCell Technologies). Colonies were scored
following 7 days in culture. For MPP colony formation [42],
early hematopoietic progenitors (Day 8) were harvested and a
single cell suspension plated at 2.5 × 104/mL in methylcult
supplemented with 1% BSA fraction V and cytokines to
promote myeloid progenitor colony formation; 25 ng/mL GM-
CSF, 100 ng/mL SCF, 10 ng/mL IL-3, 10 ng/mL IL-11, 10
ng/mL TPO, 10 ng/mL Flt3 (PeproTech™), and 1 U/mL EPO
(R&D Systems Ltd.) for 7 days. The colonies were replated in
the same cocktail for a further 7 days to assess replating
ability. To promote granulocyte/macrophage differentiation,
early hematopoietic progenitors (Day 8) were replated at 2.5 ×
104/mL in methylcult with 1% BSA and cytokines to promote
both myeloid and erythroid colony formation; 25 ng/mL GM-
CSF, 25 ng/mL G-CSF, 10 ng/mL SCF, 10 ng/mL IL-3 and 2
U/mL EPO for 7 days. Hematopoietic colonies were scored
using a Nikon Eclipse TS100 microscope and digital camera
system. Cells were harvested at day 0 (ES), day 4 (early
differentiation induction) day 8 (early hematopoietic progenitor)
β-Catenin Promotes Primitive Hematopoiesis
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and day 15 (MPP, myeloid colonies) for RNA extraction and
FACS analysis.
Results
Canonical Wnt/β-catenin signaling influences early cell
fate decisions
To determine how canonical Wnt/β-catenin signaling
influences early ES cell differentiation, we activated the
pathway either by inhibiting GSK-3 activity using BIO (ATP
competitive inhibitor) or by generating stable ES cell lines using
the tetracycline regulated system to inducibly express DP-βC
with CK1 and GSK-3 phosphorylation sites mutated to prevent
proteosomal degradation [43]. Negative regulation was
achieved using the Axin stabilizer XAV 939 (XAV). Activation of
the pathway in the absence of LIF stimulation (Figure 1A)
strongly suppressed differentiation with ES colonies sustaining
high levels of alkaline phosphatase and maintaining an
undifferentiated phenotype over 72 h (Figure 1B) whereas XAV
treatment increased differentiation (Control 45+3.1%, DP-βC
75+2.1%, BIO 86+3.2%, XAV 26+1.5%, n=3). However
canonical Wnt/β-catenin signaling was unable to sustain self-
renewal with cells undergoing a degree of differentiation by 96
h of LIF withdrawal. BIO exhibited a greater propensity to
suppress differentiation than DP-βC, indicative of GSK-3 ability
to modulate other pathways such as the PI3 kinase pathway
[44]. To determine early germ-layer fate programs during
differentiation we made use of a TaqMan® Mouse Stem Cell
Pluripotency Array, which focused on stem cell/pluripotent
markers and early differentiation lineage markers. Results
indicate that activation of canonical Wnt signaling profoundly
alters transcriptional regulation of ES cells during early
differentiation induction following LIF removal (Figure 2A). In
line with differentiation suppression, genes correlating to
‘stemness’ such as Nanog, Nr5a2, Oct3/4, Rex1, Tcf and Cdx2
were up-regulated by DP-βC expression and GSK-3 inhibition
(BIO). Furthermore β-catenin activation strongly induced a
mesodermal/mesoendodermal program with characteristic
markers Brachyury (T), Pecam 1, Nodal, Myo D1 and Tcfcp2ll
up-regulated. This was accompanied by a corresponding
suppression of endodermal genes (Col1al, Col2al, Crabp2, Nes
and Neurod 1). Semi-quantitative PCR confirmed changes in
expression of key genes significantly altered following
canonical Wnt/β-catenin signaling. In addition Sall 1 and ID 1
genes important for suppressing differentiation were down-
regulated following DP-βC expression and BIO treatment. As
predicted XAV treatment had the opposite effect, down-
regulating Nanog, Oct3/4, Brachyury, Nodal and BMP4
expression (Figure 2B). Flow cytometry analysis of key
transcription factors involved is sustaining self-renewal (Sox2,
Oct4 and Nanog) in conjunction with Brachyury indicate that in
the absence of LIF β-catenin signaling sustains expression of
these self-renewal markers whilst substantially up-regulating
Brachyury expression (Figure 2C & Figure S1A & S1B). These
findings corroborate a role for canonical Wnt signaling in
sustaining the ‘stemness’ potential of mesodermal progenitor
populations during early embryonic differentiation.
Active β-catenin indirectly regulates Nanog levels
during early differentiation
To explore the complex interplay involved in stem cell
maintenance during differentiation processes we examined the
relationship between β-catenin signaling and its ability to
regulate TCF/LEF, Brachyury, STAT3 and Nanog levels.
Immunoblotting analysis revealed that DP-βC and BIO up-
regulated/sustained higher protein levels of TCF/LEF,
Brachyury, STAT3 and Nanog during differentiation induction
(Figure 3A ). Flow cytometry also indicated that a higher
percentage of cells were positive for both Nanog and
Figure 1.  Activation of the canonical Wnt pathway
maintains self-renewal in the absence of LIF.  Parental E14
ES cells were cultured with or without BIO (5 µM) or XAV (5 or
10 µM) and DP-βC ES cells with or without Tet for 72 and 96
hours in the absence of LIF. (A) Protein extracts were
immunoblotted for key signaling proteins involved in the Wnt
pathway regulation; GSK-3, Active and total β-catenin with
GAPDH used as a loading control, (Representative gel images
shown, n=3). (B) Self-renewal potential was assessed by the
percentage of colonies staining positive for alkaline
phosphatase (AP) is given (Mean + SEMs, n=3 * p<0.05, **
p<0.005 by paired students t-test).
doi: 10.1371/journal.pone.0081030.g001
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Brachyury (Figure 3B) with a degree of co-localisation
observed between Brachyury and Nanog by
immunohistochemistry (Figure 3C). From these data we
hypothesised that β-catenin through TCF/LEF1 mediated up-
regulation of Brachyury might enhance Nanog levels.
Examination of the proximal promoter regions of Brachyury
Figure 2.  Active β-catenin directs mesodermal differentiation.  (A) Relative gene expression profile TaqMan® Mouse Stem Cell
Pluripotency Array of mRNA harvested from DP-βC (+/- Tet) or E14 ES cells (+/- 5 µM BIO) following 72 and 96 hours without LIF.
Relative expression of each gene calibrated to untreated controls (-DP-βC or -BIO) using the 2 –ΔΔCT method, plotted on a log scale
with a relative expression of 1 representing no change to gene expression (Mean + SEMs, n=3). (B) Semi-quantitative RT-PCR for
DP-βC (+/- Tet) and E14 ES cells (+/- 5 µM BIO, +/- 5 µM & 10 µM XAV) following 72 and 96 hours without LIF. (Representative gel
images shown, n=3). (C) FACS plots confirming higher levels of Sox2, Oct3/4, Nanog or Brachyury over 72 and 96 hours following
DP-βC or BIO treatment without LIF for 96 hours compared to control cells (Representative images shown, n=2).
doi: 10.1371/journal.pone.0081030.g002
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confirmed the two putative TCF/LEF1 consensus binding sites
previously reported by Arnold et al. [45], and the predicted
Brachyury consensus binding site identified in the Nanog distal
enhancer region [46]. ChIP assays were designed to explore
these interactions (Table S2). DP-βC expression and BIO
treatment resulted in a significant enrichment of the Brachyury
proximal promoter from extracts immunoprecipitated with an
anti-TCF/LEF antibody cocktail (Figure 3D), indicating
canonical Wnt signaling directly regulates Brachyury
transcription. In addition significant enrichment of the Nanog
distal enhancer was also observed from extracts
immunoprecipitated with a specific Brachyury antibody (Figure
3E and Table S3). Similar results were observed following
STAT3 immunoprecipitation using primers which span the
putative Nanog enhancer STAT3 binding site. Flow cytometry
analysis indicates that this is a sequential event with short-term
activation of β-catenin signalling rapidly up-regulating
brachyury prior to any significant changes in Nanog levels,
whereas longer-term activation led to high levels of both
brachyury and Nanog (Figure 3F and 2C). Our findings indicate
that STAT3 and Brachyury up-regulation through canonical
Wnt/β-catenin signaling may potentiate Nanog transcription by
converging on its enhancer region.
Figure 3.  Canonical Wnt signaling biases mesodermal commitment via altered TCF/LEF/Brachyury/Nanog
transcription.  (A) Protein extracts from DP-βC (+/- Tet) and E14 ES cells +/- BIO) following 96 hour culture in no LIF were
immunoblotted to measure levels of active and total β-catenin, TCF/LEF, Brachyury, pStat3, total Stat3 and Nanog with GAPDH
used as the loading control. Representative gel images shown, n=3. (B) Flow cytometry showing higher percentage of cells were
positive for both Nanog and Brachyury following DP-βC or BIO treatment without LIF for 96 hours compared to control cells
(Representative images shown, n=2). (C) Immunofluorescence to show up regulation of self-renewal markers Nanog or Stat3 and
mesodermal marker Brachyury following DP-βC expression or BIO treatment. Representative images shown, n=3. (D) Chromatin
Immunoprecipitation was performed on DP-βC (+/- Tet) and E14 ES cells (-/+ BIO) cultured in the absence of LIF for 96 hours. The
cells were harvested and IP was performed on the sonicated chromatin material using the TCF/LEF antibody sampler kit. The
primer sets were designed on regions flanking the TCF/LEF binding sites (Start -597 to Start -368 on the Brachyury promoter). (E)
In addition IP was performed using Brachyury or Stat3 antibody on the sonicated chromatin material. The primer sets were designed
on regions flanking the Brachyury binding sites (Start -4875 to Start -4476) and Stat 3 binding sites (Start -4875 to Start -4668) on
the Nanog enhancer region. Quantitative PCR was performed to measure the relative enrichment (Mean fold enrichment, +/- SEM,
n=3). (F) Flow cytometry analysis indicating short-term activation of β-catenin signalling (DP-βC or BIO) rapidly up-regulates
Brachyury prior to any significant changes in Nanog levels (Representative images shown, n=2).
doi: 10.1371/journal.pone.0081030.g003
β-Catenin Promotes Primitive Hematopoiesis
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β-catenin signaling induces genes involved in primitive
hematopoiesis
As mesodermal patterning precedes hematopoietic
development during embryogenesis, we examined whether
active β-catenin induced any master regulators involved in
establishing hematopoiesis. Following early differentiation
induction by the removal of LIF for 4 days (Figure 4A
CONDITION 1), Sca1, c-Kit and HoxB4, genes involved in HSC
formation and self-renewal were up-regulated by activation of
the pathway. In addition the specific erythroid lineage marker,
GATA1 and the common lymphoid myeloid progenitor marker,
PU-1 were also up-regulated. Although detected GATA2, Fog1
and EpoR genes involved in erythroid specification were
unchanged whereas SCL another master regulator of
hematopoiesis was undetected (Figure 4B). Early
hematopoiesis is accompanied by the production of primitive
erythrocytes which express embryonic and fetal hemoglobins.
This is a hierarchical system in-part controlled by LMO2, Tie2
and Pecam1. Activation of the Wnt pathway resulted in a
significant up-regulation of LMO2, Tie2, Pecam1 as well as the
embryonic and fetal hemoglobin genes (Figure 4B). To explore
this further, cells were directed to form EB’s and then cultured
in a cytokine cocktail to promote primitive erythroid colony
formation. Active β-catenin signaling resulted in a significant
increase in primitive erythroid colonies (Figure 4C). These
findings indicate that canonical Wnt/β-catenin signal
transduction is fundamental for inducing a hematopoietic gene
transcription program during early differentiation events in ES
cells.
β-catenin activation enhances hemangioblast/early
hematopoietic progenitor formation
Hemangioblasts establish the vasculature and hematopoietic
systems during development. To determine how β-catenin
activation influences this process, ES cells were directed to
undergo hemangioblast/early hematopoietic progenitor
formation (Figure 4A CONDITION 2). Previous studies indicate
that hemangioblasts are present in blast-like colonies (BL-CFC)
[27,31,47], we therefore scored the number of BL-CFC
compared to the number of EB’s for each condition. Activation
of the canonical Wnt pathway led to a higher percentage of BL-
CFC compared to control cultures by day 8 of differentiation
(Figure 5A (i)). The total cell population generated was
analysed for the key endothelial markers Flk1, CD44 and the
mesodermal marker brachyury by flow cytometry and revealed
that a greater percentage of cells expressed these markers
following β-catenin expression or BIO treatment than in the
control cultures, indicative of enhanced hemangioblast
Figure 4.  Active β-catenin induces an embryonic erythroid program during early differentiation.  (A) Schematic diagram of
the different differentiation stages examined. CONDITION 1 early differentiation, CONDITION 2 Hemangioblast/Early hematopoietic
progenitors, CONDITION 3 MPP, MEP and GMP differentiation, CONDITION 4 Myeloid colony formation. (B) QRT-PCR
demonstrating activation of the canonical Wnt signaling (DP-βC or E14 ES cells + BIO) up-regulates key genes important for
establishing early hematopoietic commitment, primitive erythroid specification and embryonic/fetal globin genes during
differentiation induction in the absence of LIF (CONDITION 1). Control cells (DP-βC + tet or E14 ES cells -BIO) were used as
calibrators and the fold change was calculated using the 2 –ΔΔCT method (Mean of fold change +/- SEM, n=3). (C) Cells were directed
to form EB’s and then cultured in M3434 to promote primitive erythroid colony formation and colonies scored. Active β-catenin
signalling (DP-βC or BIO) resulted in a significant increase in primitive erythroid colonies (Mean %, +/- SEM, n=3).
doi: 10.1371/journal.pone.0081030.g004
β-Catenin Promotes Primitive Hematopoiesis
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formation [34] (Figure 5A (ii), Figure S2 and summarised in
Table 1). Gene transcription analysis also confirmed higher
levels of Brachyury and Flk1 expression in line with the
increase shown by flow cytometry. In addition GATA 3 & 4
were up-regulated and Nanog and Oct3/4 down-regulated,
confirming enhanced differentiation (Figure 5A (iii)). Flow
cytometry analysis was also performed to determine the
percentage of cells expressing the early hematopoietic
progenitor markers CD41, CD45, c-Kit, Sca1 and Flt3. Gating
on the CD41+, CD45+ population revealed that these early
hematopoietic progenitors also expressed the HSC markers
Sca1 and c-Kit (Figure 5B) with a very high percentage of
CD41+ cells also co-expressing Sca-1 (Table 1). β-catenin
signaling resulted in a significant increase in early
hematopoietic/progenitor cells with more cells expressing the
blood cell marker CD45 (Figure S2 and summarised in Table
1).
To ascertain whether the (Sca1+, c-Kit+) hematopoietic
progenitor populations had alteration in their lineage priming
potential following activation of the canonical Wnt pathway we
isolated this population by FACs sorting for further analysis
Table 1. FACS analysis: Hemangioblasts.
% Markers Control DP-βC E14±BIO
Brachyury 48.7 ± 4.4 61.0 ± 1.5* 64.7 ± 2.3**
Flk1 44.9 ± 1.7 63.1 ± 4.3* 64.2 ± 4.0*
CD44 65.2 ± 0.9 72.0 ± 2.0* 69.2 ± 2.6**
Flt3 49.9 ± 1.7 73.0 ± 1.4** 72.0 ± 2.4**
CD41 46.5 ± 10.6 60.5 ± 9.2* 62.9 ± 7.1*
Sca1 52.6 ± 4.2 72.0 ± 3.3** 66.1 ± 3.2*
c-Kit 52.1 ± 3.2 71.3 ± 3.1* 69.5 ± 3.4*
CD45 25.9± 2.8 39.6 ± 2.3** 44.3 ± 3.6*
CD41±CD45± 18.2 ± 3.2 30.7 ± 4.0* 32.6 ± 2.7*
Sca1 31.3 ± 5.3 48.3 ± 3.8* 51.9 ± 1.6*
c-Kit 11.1 ± 2.0 21.0 ± 2.8 16.1 ± 2.6
CD41±Sca1± 36.5 ± 2.5 51.5 ± 2.7* 52.7 ± 3.3*
Average % ± SEM, n=3 (* p<0.05, ** p<0.005)
doi: 10.1371/journal.pone.0081030.t001
Figure 5.  β-catenin activation enhances hemangioblast formation.  (A) (i) Scoring of the number of BL-CFC compared to the
number of EB’s for each condition by day 8 of differentiation shows activation of the canonical Wnt pathway (DP-βC or BIO) results
in higher percentage of BL-CFC compared to control cultures (Mean %, +/- SEM, n=3). (ii) Hemangioblasts/Early hematopoietic
progenitors (CONDITION 2) were analysis for expression of mesodermal markers Flk1 and Brachyury by flow cytometry. (iii) RT-
PCR analysis of key self-renewal and differentiation genes. (B) Flow cytometry analysis was performed on the hemangioblast/early
hematopoietic progenitors to determine the percentage of cells expressing CD41, CD45, c-Kit, Sca1 and Flt3. Gating on the CD41+,
CD45+ population revealed that these early hematopoietic progenitors also expressed the HSC markers Sca1 and c-Kit
(Representative images shown, n=3). (C) (i) Total cell population from CONDITION 2 were analyzed for key HSC markers Sca1 and
c-Kit by flow cytometry. (ii) The early hematopoietic progenitor populations (Sca1+c-Kit+ cells) were sorted and Immunofluorescence
performed to confirm higher levels of total and active β-catenin in DP-βC –tet and E14 cells + BIO. (iii) RT-PCR analysis of key
hematopoietic genes within the Sca-1+c-kit+ hematopoietic progenitor cells and (iv) erythroid/globin genes. The control cells (DP-βC
+ tet or E14 ES cells -BIO) were used as calibrators and the fold change was calculated using the 2 -ΔΔCT method (Mean of fold
change +/- SEM, n=3).
doi: 10.1371/journal.pone.0081030.g005
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(Figure 5C (i)). First we confirmed that the activated cells still
had higher levels of total and active β-catenin expression
(Figure 5C(ii)). Next we carried out gene profiling of the Sca1+,
c-Kit+, which revealed β-catenin signaling significantly up-
regulated key regulators of HSC formation and self-renewal (c-
Kit, Sca1 & HoxB4) and master regulators of hematopoietic
lineage commitment (SCL/Tal-1, GATA 1 & 2, PU-1, Fog1 &
EpoR) compared to the control populations (Figure 5C (iii)); as
well as genes involved in establishing primitive and more
definitive erythropoiesis (Figure 5C (iii & iv)). A similar gene
profile was observed when the total population containing both
the hemangioblast/early hematopoietic population was
analysed (Figure S3). Overall these data indicate a crucial role
for β-catenin in establishing embryonic hematopoiesis.
Active β-catenin biases MEP formation
Our early differentiation results indicate that active β-catenin
signaling, in the absence of erythropoietin stimulation, primes
cells to undergo an erythroid differentiation program. To
explore this in more detail we plated the early hematopoietc
progenitor cells in a cytokine cocktail which promotes MPP,
MEP and GMP formation (Figure 4A, CONDITION 3) [42].
Following seven days in culture, cells were analyzed by multi-
parameter flow cytometry for MPP, MEP and GMP populations.
The results revealed β-catenin signaling enhanced early
hematopoietic progenitor/MPP populations as measured by c-
Kit, Sca1 and Flt3 expression (Summarised in Table 2A). In
addition high levels of the early erythroid marker CD24 was
also observed (Figure S4). In adult mice, levels of Sca1 and c-
Kit are routinely used as surrogate markers for HSC/
progenitors with long-term and short-term repopulating
capacity. We therefore gated on the putative lineage restricted
long-term (LT) HSC/progenitor population (Sca1hic-Kitlo) in our
cultures for CD41 and CD71 expression. Results indicate a
significant increase in the percentage of cells expressing these
MEP markers in the DP-βC and BIO treated cultures (Figure
6A, middle panel). A similar trend was also observed in the
putative short-term (ST) HSC/progenitor population (Sca1loc-
Kithi) (Figure 6A, lower panel), indicating β-catenin signaling
increases MPP and MEP formation. To assess the self-renewal
potential of the MPP populations, cells from the first round were
replated. Following a further 7 days in culture, analysis
revealed that DP-βC and BIO treatment impeded differentiation
with a significantly higher percentage of cells sustaining Sca1
and c-Kit expression (Figure 6B and Table 2B), confirming a
higher percentage of cells with LT-HSC/progenitor potential
were present in the first round of MPP differentiation. Gating
these putative LT-HSC/progenitor and ST-HSC/progenitor
populations also revealed a higher percentage of cells co-
expressing the MEP markers CD41 and CD71 indicative of the
canonical Wnt pathway inducing an erythroid differentiation
program (Figure 6B).
Active β-catenin permits granulocyte-macrophage
colony formation
To determine whether active β-catenin blocked granulocyte-
macrophage (GM) colony formation we employed a cytokine
cocktail which strongly promotes CFU-GM whilst permitting
BFU-E and GEMM formation (Figure 4A CONDITION 4). As
predicted by the strong erythroid program induced during
differentiation induction by both DP-βC and BIO, a significant
enhancement in BFU-E and GEMM formation was observed
(Figure 7A). However, high numbers of CFU-GM still formed in
both the DP-βC and BIO cultures. These changes were
supported by an up-regulation of the HSC regulators GATA1,
Klf-1, Fog1 and EPO-R along with the adult globin genes Hbb-
b1, Hbb-b2, whereas the monocytic specific genes Egr1 & 2
(Figures 7B) were down-regulated.
Discussion
The canonical Wnt/GSK3β/β-catenin pathway is known to
act synergistically with the LIF/STAT-3 pathway to improve ES
cell self-renewal [48-50]. However, information is limited on its
role during early differentiation decisions, especially embryonic
hematopoiesis. Our data indicates that during differentiation
induction following LIF withdrawal, β-catenin suppresses this
Table 2. FACS analysis.
MPP
% Markers Control DP-βC E14±BIO
Sca1 39.7 ± 5.2 54 ± 3.6* 57.2 ± 3.8**
c-Kit 9.5 ± 2 17.4 ± 3.1** 18.4 ± 2.3*
CD24 54.6 ± 5.8 68 ± 4.3* 64 ± 2.2*
Ter119 1.2 ± 0.4 7.3 ± 0.3* 4.5 ± 0.2*
Gr1 2.9 ± 0.9 1.6 ± 0.5 1.1 ± 0.4
Flt3 0.9 ± 0.2 2.7 ± 0.3 2.2 ± 0.7
Sca1hiKitlo    
CD45 66.0 ± 7.9 78.7 ± 5* 85 ± 1**
CD41 39.4 ± 3.1 60.2 ± 3.7** 57.3 ± 3*
CD71 58.1 ± 3.4 71.3 ± 2.5** 68.9 ± 4.3*
Sca1loKithi    
CD45 14.4 ± 2.1 20.6 ± 2.3 25.1 ± 1.6*
CD41 27.2 ± 2.7 43 ± 4.5* 41.3 ± 2.1*
CD71 60.9 ± 6.1 73.7 ± 3.9** 77 ± 3.6*
MPP Replates
% Markers Control DP-βC E14±BIO
Sca1 44.6 ± 3 55.6 ± 3.4* 57.3 ± 4*
c-Kit 7.6 ± 2.5 13.9 ± 2.2* 17.4 ± 3*
CD24 65.7 ± 6.3 74.3 ± 3.8* 71.4 ± 4.5**
Ter119 0.2 ± 0.0 0.04 ± 0.0 1.2 ± 0.6
Gr1 4.2 ± 0.3 0.7 ± 0.2* 2.1 ± 0.6*
Flt3 0.3 ± 0.1 0.03 ± 0.0 1.3 ± 0.1
Sca1hiKitlo    
CD45 82.6 ± 3.5 92.5 ± 3.2* 88.7 ± 4.2*
CD41 49.1 ± 2.4 59 ± 3.5 63.6 ± 3.4*
CD71 60.2 ± 4.5 64.3 ± 5.6* 68.4 ± 3.7*
Sca1loKithi    
CD45 21.0 ± 2.3 13.1 ± 2.2* 15.2 ± 2.4*
CD41 30.3 ± 2.7 43.0 ± 3.6** 38.9 ± 4*
CD71 62.5 ± 3.7 68.3 ± 4.8* 70.4 ± 3.3
Average % ± SEM, n=3 (* p<0.05, ** p<0.005)
doi: 10.1371/journal.pone.0081030.t002
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process whilst promoting mesodermal cell fate determination.
Cells treated with BIO or induced to express active β-catenin,
retained alkaline phosphatase staining and had higher
expression levels ofkey pluripotency markers Oct3/4, Nanog
and Sox2. These findings were confirmed at the transcription
level with pluripotency genes, especially Oct3/4, Nanog, Sox2
and Rex1all up-regulated. Genes involved in mesodermal
patterning were also up-regulated following activation of the β-
catenin pathway. In particular the T-box targets Eomesogermin
(Eomes) and Braychury (T) were significantly up-regulated.
During mouse development Eomes is the earliest regulator of
mesoderm formation being required for both embryonic and
extraembryonic mesoderm formation [51]. T overlaps with
Eomes, with T also implicated in later processes such as left/
right axis determination and somite segmentation [52]. In
addition mesoendoderm specification genes were also up-
regulated, these included; Fgf4 expressed in intermediate
mesoderm [53], GATA 4 and 6 expressed in lateral mesoderm
during organogenesis [54,55], Lefty 1 & 2 and Nodal involved
in left/right axis determination, and lateral plate mesoderm
formation during gastrulation [56,57]. A previous study using β-
catenin knock-out ES cells showed an inverse correlation to
our findings with genes including Nanog, Rex1, Lefty1 and
Lefty2 all down-regulated [57]. These data support the idea that
β-catenin is intricately involved in regulating the expression of
Nanog. Using flow cytometry and ChIP technology we
demonstrate that a complex relationship exists between β-
catenin signaling and LEF/TCF/Brachyury/Nanog levels.
Following β-catenin activation, TCF/LEF could potentially
directly bind to its consensus sites in the Brachyury promoter
[45] leading to the higher levels of Brachyury expression we
observe. This in turn may enable Brachyury to bindto the distal
enhancer site of Nanog downstream of STAT3, to potentiate
Nanog expression. Our data demonstrates that Brachyury up-
regulation precedes Nanog supporting this potential
mechanism. These findings are also supported by a previous
study whereby BMP in combination with LIF signaling was able
to indirectly augment Nanog expression through Brachyury,
causing ES cells to become early-mesoderm cells [46,58]. Our
findings provide a potential mechanism through which active β-
catenin sustains stem cell potential during early mesoderm
specification. These findings contribute to our understanding of
how Wnt signalling controls ES fate decisions. Previous studies
indicate that Wnt in combination with LIF signalling is
fundamental for sustaining pluripotency and germ line
transmission. When Wnt signalling is blocked, LIF in the
absence of Wnt signalling results in ES cells differentiating into
epiblast stem cells [59] whereas our findings indicate that Wnt
signaling in the absence of LIF results in the induction of a
mesodermal cell fate.
Recent studies report Wnt, along with Activin and BMP
signals are important for hematopoietic development, with
inhibition of Wnt signaling preventing the formation of Flk1+
mesoderm followed by a reduction in CD41+ primitive erythroid
colony formation [35]. Conversely Wnt pathway activation
enhanced hematopoiesis through up-regulation of SCL and T3
globin transcription [9]. Wnt family members are highly
expressed in the YS, AGM and FL during embryogenesis with
several members including non-canonical Wnt 4, 5a and 16
and canonical Wnt 3a known to be important for establishing
embryonic hematopoiesis [1,5,7-9,13,26,60]. Indeed Wnt
signaling is essential for HSC generation from the AGM region
at E10.5 [14], however how canonical Wnt signaling specifies
early hematopoietic commitment is still unclear. We therefore
used our ES differentiation system and performed detailed
gene analysis of the transcriptional complexes involved in
Figure 6.  Activation of the canonical Wnt pathway increases MPP and MEP generation.  (A) Cells from CONDITION 2 of the
differentiation, (DP-βC +/- Tet and E14 ES cells +/- BIO) were cultured in a MPP cocktail for 7 days prior to multi-parameter flow
cytometry analysis of total cell population from CONDITION 3. Live cells from CONDITION 3 of the differentiation were gated and
the expression of the hematopoietic progenitor markers, Sca1hic-Kitlo and Sca1loc-Kithi were profiled along with the megakaryocytic
marker CD41 and transferrin receptor CD71. (B) MPP population (CONDITION 3) were then replated for an additional 7 days and
analyzed for the same panel of markers outlined in (A). Images are representative of 3 independent experiments.
doi: 10.1371/journal.pone.0081030.g006
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establishing primitive hematopoiesis in order to understand
how the Wnt pathway regulates this process early on during
differentiation. In cells induced to differentiation by the removal
of LIF for 4 days we clearly demonstrate that β-catenin
signaling up-regulates Kit, CD34 and Pecam 1, genes which
mark the onset of primitive hematopoietic cell establishment
from extraembryonic mesoderm and YS development [34,61].
Along with significantly up-regulating key genes involved in
Figure 7.  β-catenin permits granulocytic/macrophage
colony formation.  (A) Cells from CONDITION 2 of the
differentiation, were directed to undergo myeloid colony
formation and the number of GM-CFU, GEMM, and BFU-E
colonies counted-CONDITION 4. Graph represents the Mean
% +/- SEM, n=3. Representative pictures of hematopoietic
colonies x 10 magnification, scale bar 100 µM. (B) Gene
expression profiling of erythroid and myeloid genes. The
control cells (DP-βC +Tet or E14 ES cells -BIO) were used as
calibrators and the fold change was calculated using the 2 –ΔΔCT
method (Mean of fold change +/- SEM, n=3).
doi: 10.1371/journal.pone.0081030.g007
establishing primitive erythropoiesis including; GATA1, Pecam
1, Tie2 and LMO2 with no change in GATA2, Fog1 and EpoR
levels. It is known that primitive erythroid cells arise from
GATA1 and 2 expressing cells in the YS which also have
endothelial potential and express the endothelial markers Flk1,
Tie2 and Pecam 1 [61]. GATA2 null mice are embryonic lethal,
due to severe anemia during the early phase of YS
hematopoiesis (E10-11) [62]. Expression of GATA2 precedes
GATA1 and must decrease as GATA1 expression increases to
enable erythroid differentiation. Another transcription factor
essential for primitive hematopoiesis and induced by GATA2 is
LMO2. LMO2 null mice die around E9 of severe anemia, with a
lack of any YS hematopoiesis [63,64]. TCF transcription factors
in concert with cell specific master regulators, including GATA
1 and 2 and C/EBPα, have recently been shown to selectively
bind to the enhancer region of lineage-distinctive genes to
promote erythroid and myeloid differentiation programs.
Following Wnt signalling TCF7L2 co-operated with GATA2 to
increase LMO2 transcription [65]. LMO2 then acts in a complex
with GATA1 and SCL to facilitate DNA binding and erythroid
gene transcription [66]. Key erythroid genes regulated by
GATA1 and 2 include the globins, EKLF, Fog, EpoR and heme
biosynthesis enzymes [67,68]. Considering the essential role
these transcription factors play in generating primitive erythroid
cells, we also examined globin gene expression. The initially
expressed globin genes are Hbz and Hbb-βH1 which are then
superseded by the Hba-α1, Hba-α2 and ɛy- globin genes, as
proerythroblasts at E7.5 transition to reticulocytes at E15.5
[69]. Our data established a sequential up-regulation of
embryonic and fetal globin genes by Wnt signaling during early
hematopoietic specification, with the adult globins being up-
regulated at the later stages of hematopoietic differentiation.
This is the first report of β-catenin signaling affecting globin
switching and corroborate the Nostro et al. demonstrated that
over expression of β-catenin enhanced primitive erythroid
progenitor formation [35]. Taken together these findings
validate a role for this pathway in orchestrating primitive
erythropoiesis.
The transition from primitive to more definitive hematopoiesis
involves the formation of hematopoietic progenitors with self-
renewing potential. In order to explore how β-catenin
influenced this process we directed ES cells to form
hemangioblast/early hematopoietic progenitors. Active β-
catenin significantly augmented this process with 60-75% of
the cells expressing the early HSC/progenitor markers CD41,
c-Kit, Sca1 and Flt3 compared to ~50% in the control cultures,
with 40% of the cells also expressing the pan-hematopoietic
marker CD45 compared to 25% in the control cultures.
Isolation of the Sca1+c-Kit+ population followed by gene
profiling revealed that transcription factors involved in HSC
specification and self-renewal were strongly up-regulated in
these early hematopoietic progenitors by β-catenin signaling,
including SCL/Tal1, essential for initiating the hematopoietic
program at this stage [70]. Genes essential for erythroid
lineage priming were also up-regulated including the adult
globin genes necessary to switch from primitive to definitive
erythropoiesis. Given that during CONDITION 1 of
differentiation the cells had been cultured in the absence of
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growth factors and by CONDITION 2 in growth factors which
promote mesoderm followed by hemagioblast/early
hematopoietic progenitor formation in the absence of
erythropoietin, these findings provide important insight into the
role canonical Wnt signaling plays in establishing the
hematopoietic system during early development.
In order to determine how influential canonical Wnt signaling
was in predisposing cells to undergo erythropoiesis, the early
hematopoietic progenitor population were cultured in a cytokine
cocktail to promote MPP formation [42]. Active β-catenin
resulted in a higher percentage of cells sustaining expression
of the early HSC/progenitor markers Sca1/c-Kit, along with the
immature hematopoietic lineage marker CD24, which persists
during erythrocyte differentiation [71]. CD41 a Runx-1/SCL
regulated marker [72–75] was also highly expressed following
β-catenin signaling. In combination with CD71, CD41
expression can be used to characterise MEP progenitors.
Following MPP culture, active β-catenin increased the number
of cells with MEP potential (Ter119loCD41hiCD71hi) within both
the Sca1hic-Kitlo and Sca1loc-Kithi populations. Following MPP
replating, β-catenin signaling sustained the number of Sca1hic-
Kitlo cells. This is in accordance with the mouse models where
conditional expression of active β-catenin in the hematopoietic
system results in a large expansion of Sca1+c-Kit+ LT-HSC.
Analysis revealed that these HSCs were unable to sustain
long-term reconstitution ability following transplantation. This
was due to β-catenin pushing cells into cycle increasing
proliferation and leading to the accumulation of undifferentiated
progenitors which eventually resulted in HSC exhaustion. In
addition the progenitors generated exhibited defective GM
colony forming ability and enhanced potential to undergo
erythroid differentiation in vitro and in vivo reflected by higher
erythroid cell numbers in the bone marrow and spleen [21,22].
Recent evidence indicates that the level of canonical Wnt
signaling can greatly affect HSC behaviour, with moderate to
low levels of activation being advantageous whereas sustained
high levels are detrimental leading to a differentiation block and
an inability of HSC to reconstitute lethally irradiated recipients
[26]. In our in vitro model cytokine signaling through G-CSF
and GM-CSF was able to partially overcome this block in GM
colony formation, supporting the idea that although β-catenin
promotes an erythroid transcriptional program, the HSC/
progenitor populations still retain the capacity to undergo
granulocyte/macrophage differentiation.
Overall we demonstrate the transcriptional changes
canonical Wnt signaling alters to orchestrate early
developmental hematopoietic stages. Our data clearly defines
a role for β-catenin in directing ES cells to form mesodermal
progenitors and enhancing the formation of hematopoietic
progenitors with erythrocytic potential. In addition β-catenin
induced expression of genes involved in maintaining stem cell
potential during these early differentiation decisions, an
essential process necessary for sustaining the rapid
proliferation required during the establishment of the
hematopoietic system.
Supporting Information
Figure S1.  Wnt signaling up-regulates brachyury levels in
the absence of LIF (A). Dot plots and graphs showing DP-βC
expression or BIO treatment increases the percentage of cells
expressing Brachyury over 72 and 96 hours following LIF
withdrawal. (Representative images shown, graph of Mean %
+/- SEMs, n=3). Activating the β-catenin pathway sustains
Nanog, and Oct3/4 expression following LIF removal (B).
Representative histograms showing DP-βC expression or BIO
treatment sustains the percentage of cells expressing Nanog
and Oct3/4 over 72 and 96 hours to similar levels as observed
at 20h following LIF withdrawal.
(TIF)
Figure S2.  β-catenin activation enhances hemangioblast
and hematopioetic markers during differentiation. FACS
analysis to measure percentage of cells expressing
hemangioblast and hematopoietic markers following DP-βC
expression or BIO treatment. Activation of the pathway up-
regulates the mesodermal marker Brachyury along with
mesoendodermal Flk1 and CD44. Analysis also shows that
HSC markers (Sca1 & c-Kit), myeloid progenitor marker (Flt3)
and hematopoietic cell marker (CD45) are all up-regulated by
activation of the canonical Wnt pathway (Representative
histograms shown, n=3).
(TIF)
Figure S3.  Early hematopoietic progenitors up-regulate
early and late erythroid genes following canonical
signalling. RT-PCR analysis for the total hemangioblast/
hematopoietic progenitor populations (i) key hematopoietic
genes (ii) erythroid/globin genes. The control cells (DP-βC + tet
or E14 ES cells -BIO) were used as calibrators and the fold
change was calculated using the 2 -ΔΔCT method (Mean of fold
change +/- SEM, n=3).
(TIF)
Figure S4.  Activation of the canonical Wnt pathway
increases MPP and MEP generation. Multi-parameter flow
cytometry analysis of the MPP populations following DP-βC
expression and BIO treatment. The dot plots represent the
expression profiles for CD24, Ter119, Gr1 and Flt3 after the
first round of MPP formation and following replating for an
additional 7 days in the MPP cytokine cocktail. Representative
dot plots shown, n=3.
(TIF)
Table S1.  Table showing the CT, ΔΔCT and Fold change
values for ChIP data. Gels depicting levels of Brachyury or
Nanog following IP for the TCF or the Brachyury promoter
respectively between treated (DP-βC or BIO) and control
samples with Rabbit IgG used as a negative control.
(TIF)
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Table S2.  Table showing the forward and the reverse
primers used in the ChIP assays in this study and the
sizes for each product with respect to the start site.
(TIF)
Table S3.  Tables showing the primer sequence, accession
numbers and the cycling conditions for the forward and
reverse primers used in this study.
(TIF)
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